FS Arzneimittelindustrie e.V.

Dr. Holger Diener - Geschäftsführer
Daniela von Arnim - Assistentin

Grolmanstr. 44-45
10623 Berlin

Tel.: 030 88728-1700
Fax: 030 88728-1705

Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V.

Members of the Healthcare Profession


Transparency can only function if all the partners are in agreement. We believe that there are excellent reasons for further strengthening trust and thus combating distrust through these measures.

It is also clear, however, that the express consent of physicians and other members of healthcare professions is an indispensable prerequisite – and not simply because the federal data protection act prescribes it.

That is why in the coming weeks and months, the member companies of the FSA will be increasingly narrating this current development and intensively promoting additional consent. A key objective in this is to limit the legally required bureaucratic overhead to a minimum.

As a healthcare professional or organisation in the healthcare field, please speak directly with your contacts in the company, should questions or queries arise.




Information on the „Freiwillige Selbstkontrolle für die Arzneimittelindustrie e. V.“ (FSA) is available at


Current News

New Press Release: Research-based pharmaceutical companies implement Transparency Code


The International Olympic Committee published its indemnity policy for the first time to increase transparency within the organization


Allergo Journal "wholeheartedly" supports the transparency initiative of the FSA


Survey: Most Physicians Report Being Unaffected By Open Payments Database.


Disclosure of payments to health professionals: Going Live


Press Contact

wbpr_ Kommunikation
Natalie Schneider
Phone: +49 89/99 59 06-25
Email: natalie.schneider@wbpr.de